Biotech Values

[DewDiligence]

ACAD/ADMS/CEMP/EPZM/OTIC/PRTA/SAGE/TXMD—Financing transactions…

• ACAD ($345M*):
http://finance.yahoo.com/news/acadia-pharmaceuticals-announces-proposed-public-210500610.html

• ADMS (2.875M* shares):
http://finance.yahoo.com/news/adamas-announces-proposed-public-offering-121500663.html

• CEMP ($201.3M*):
http://finance.yahoo.com/news/cempra-announces-proposed-public-offering-211119061.html

• EPZM ($138M*):
http://finance.yahoo.com/news/epizyme-announces-proposed-public-offering-210100700.html

• OTIC (~$115M*):
http://finance.yahoo.com/news/otonomy-announces-proposed-public-offering-210100982.html

• PRTA (2.59M* shares):
http://finance.yahoo.com/news/prothena-announces-proposed-offering-ordinary-210302034.html

• SAGE ($172.5M*)
http://finance.yahoo.com/news/sage-therapeutics-announces-proposed-public-210926802.html

• TXMD ($143.8M*):
http://finance.yahoo.com/news/therapeuticsmd-announces-125-million-offering-210100624.html

The ADMS offering was announced this morning; the others were announced today after the close.

*Assuming exercise of underwriter’s option.